Search
for
Sort by
Research 121–150 of 609
- Pediatric Features of Genetic Predisposition to Polycystic Ovary Syndrome
- INFLUENCE OF LIFESTYLE ON THE PROGNOSIS OF POLYCYSTIC OVARY SYNDROME
- Transgender health and the impact of aging and menopause
- Reconsidering the Polycystic Ovary Syndrome (PCOS)
- Factors associated with early-onset androgenetic alopecia: A scoping review
- Long COVID syndrome: An unfolding enigma
- Metabolic dysfunction-associated steatotic liver disease is associated with androgenetic alopecia in adults with stronger effects in women and unhealthy lifestyles
- Understanding of a Veiled Illness: Evaluation of Polycystic Ovarian Syndrome awareness (PCOS) in Young Female Students of Karachi.
- Pharmacological management of polycystic ovary syndrome
- EFFECTS OF HORMONAL THERAPY IN TRANSGENDERS
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Obesity and hyperandrogenism are implicated with anxiety, depression and food cravings in women with polycystic ovary syndrome.
- Elevated serum chromogranin A levels are independently associated with metabolic and inflammatory disturbances in polycystic ovary syndrome
- Polycystic Ovary Syndrome: A Complex Interplay of Hormones and Metabolism
- Peer Review #4 of "The mediation role of sleep on the relationship between drinks behavior and female androgenetic alopecia (v0.1)"
- Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
- Metabolic Aspects of Polycystic Ovary Syndrome
- Farmácia Sanches - Leiria e nos Serviços Farmacêuticos do Hospital Lusíadas - Porto
- The Immun System Response İn Covıd-19 Infectıon İn Polycystıc Ovary Syndrome
- Cardiovascular Disease-Associated Skin Conditions
- Female Serum HER2 Expression: Its Association With Metabolic Syndrome and Treatment Drug Response
- Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
- Polycystic ovary syndrome
- Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Polymorphisms of the genes ABCG2, SLC22A12 and XDH and their relation with hyperuricemia and hypercholesterolemia in Mexican young adults
- Pediatric Endocrine-Disrupting Chemical Exposure Produces Irreversible Organizational Injury: Biomarker Evidence Necessitating a Precautionary Public Health Framework
- Epidemiology, diagnosis, and management of polycystic ovary syndrome
- [Association between androgenetic alopecia and metabolic syndrome: a meta-analysis].